Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients
(2015) Journal of Antimicrobial Chemotherapy — Vol. 70, n° 5, p. 1596-1598 (2015)
Files
2015-JAC-Chalhoub.pdf
Restricted Access - Adobe PDF
- 80.19 KB
Details
- Authors
- Affiliations
Citations
Chalhoub, H., Tunney, M., Elborn, J. S., Vergison, A., Denis, O., Plésiat, P., Kahl, B. C., Van Bambeke, F., & Tulkens, P. M. (2015). Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. Journal of Antimicrobial Chemotherapy, 70(5), 1596-1598. https://doi.org/10.1093/jac/dku551 (Original work published 2015)